Pilonidal Disease Clinical Trial
Official title:
A Prospective Randomized Open-Label Study Examining the Efficacy of Drawtex® Hydroconductive Wound Dressing and Negative Pressure Wound Therapy in Pilonidal Cystectomy Wounds Healing by Secondary Intention - A Pilot Study
NCT number | NCT01857128 |
Other study ID # | 382094-2 |
Secondary ID | |
Status | Recruiting |
Phase | Phase 4 |
First received | May 7, 2013 |
Last updated | May 17, 2013 |
Start date | March 2013 |
The purpose of the study is to learn about the best way to treat pilonidal cyst wounds and learn which type of bandage (or dressing) can help the wound heal faster after having surgery.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | |
Est. primary completion date | December 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: 1. Healthy adult male or non-lactating female age 18 to 60 years inclusive. 2. Diagnosis of pilonidal disease with cyst requiring surgery, with undermining to remove the cyst and requiring limited excision with healing by secondary intension. 3. Presence of chronic symptomatic pilonidal disease defined as at least one pilonidal sinus and a history of at least two acute pilonidal abscesses or persistent symptoms altering patient's quality of life. 4. Military active duty members need a supervisor signed memorandum to participate (Active Duty Supervisor's Approval Memo). 5. Understands the purpose and risks of study by scoring 80% or higher on knowledge assessment test. 6. Available and willing to participate for the duration of the study (approximately 30-270 days maximum depending on time to wound healing). 7. Available and willing to provide written informed consent. 8. Able and willing to follow instructions as per protocol. 9. Available for all visits as per protocol. Post Surgery Study Enrollment Criteria 10. Post-surgical wound measurement (length x width x depth): (cm x 1.5 cm x 1.5 cm)greater than or equal to 3 cm in length, greater than or equal to 1.5 cm in width, and greater than or equal to1.5 cm in depth. Rationale: satisfies the minimum size wound that NPWT may be employed. Exclusion Criteria: 1. Does not meet all inclusion criteria. 2. Pregnant (by history or as ascertained by pregnancy test) or lactating female Rationale: immune modulation and potential for altered healing trajectory as well as operative risk to fetus for elective procedure. 3. Known HIV infection. 4. Known immunodeficiency or currently receiving immunosuppressive therapy (inhaled and topical steroids are allowed). 5. Autoimmune disease (clinical, preexisting anti-dsDNA antibodies 30 IU, or positive ANA ELISA with a titer greater than 1:80 on pre-operative screening) Exclusionary medical histories will include the following diagnoses: systemic lupus erythematosus, rheumatoid arthritis, mixed connective tissue disease, progressive systemic sclerosis, Sjogren's syndrome, polymyositis/ dermatomyositis, and vasculitis Rationale: potential for altered wound healing. 6. Acute or chronic, clinically significant cardiac, pulmonary, hepatic, or renal abnormality, as determined by physical examination or basic laboratory screening performed at pre-operative evaluation. 7. Known documented history of diabetes mellitus. 8. Non-ambulatory or limited mobility. Rationale: non ambulatory patients may have altered wound healing in the sacral area due to constant pressure from positioning. 9. History of current tobacco use: defined as cigarette smoking greater than or equal to one half pack (10 cigarettes) per day: Rationale: confounding factor prolonging wound healing. 10. Complex pilonidal disease determined by the surgeon to require a procedure other than the study procedure for appropriate treatment of the disease. 11. Acute pilonidal abscess or infection within 6 weeks of planned operative date. 12. Concerns for arterial bleeding or cancer in the wound bed or in the vicinity of the dressing. 13. Any other significant finding which, in the opinion of the investigator, would increase the subject's risk of having an adverse outcome from participating in this protocol. 14. Lack of or unwillingness to provide/sign informed consent. Post Surgery Exclusion Study Criteria 15. Post-surgical wound measurement restrictions (enth x width x depth): (0 cm x 10 cm x 6 cm)greater than or equal to 10 cm in length, greater than or equal to 10 cm in width OR greater than or equal to 6 cm in depth. If bone is visible or exposed, the subject must be excluded. Rationale: large wounds are deemed complex and wounds with exposed or visible bone require antibiotic therapy. |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Walter Reed National Military Medical Center -Dept of General Surgery | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
Walter Reed National Military Medical Center | United States Department of Defense |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time to wound healing | Time (days) to 100% epithelialization of the wound bed will be evaluated using digitized planimetry in a random manner by two independent evaluators blinded to the study treatment. | Up to 270 days or 9 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03276065 -
Effectiveness of Laser Hair Removal in Pilonidal Disease
|
N/A | |
Completed |
NCT06206330 -
Effect of Platelet Rich Plasma (PRP) on Healing Time in Patients Following Pilonidal Sinus Surgery
|
N/A | |
Recruiting |
NCT03483480 -
Non-Powered Negative Pressure Wound Therapy vs Open Technique for Pilonidal Disease
|
N/A | |
Not yet recruiting |
NCT06140199 -
Comparing Minimally Invasive Treatments for Pilonidal Disease: LA POPA Trial (Laser And Pit-picking OR Pit-picking Alone)
|
N/A | |
Recruiting |
NCT06391307 -
The Role of Mesenchymal Stem Cell and Exosome in Treating Pilonidal Sinus Disease in Children
|
N/A | |
Not yet recruiting |
NCT06286397 -
Topical Anti-Androgens in Pilonidal Sinus Disease
|
Phase 2 | |
Not yet recruiting |
NCT03415347 -
De-roofing and Curettage vs WLE for Pilonidal Abscess
|
N/A | |
Terminated |
NCT04041037 -
The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series
|
||
Not yet recruiting |
NCT06406621 -
Laser Hair Depilation Darker Skin Pilonidal Disease
|
N/A | |
Completed |
NCT05569135 -
Debridement and Laser Ablation Versus Debridement Alone in Pilonidal Disease
|
||
Completed |
NCT04697082 -
Application of Platelet-rich Plasma in Pilonidal Sinus Disease
|
N/A | |
Terminated |
NCT03534700 -
Excision and Reconstruction of the Natal Cleft With a Parasacral Perforator Flap Versus Open Excision With Secondary Healing, in the Management of Sacrococcygeal Pilonidal Disease.
|
N/A | |
Recruiting |
NCT05439291 -
Comparing Operative vs Non Operative Treatment for Pilonidal Disease
|
N/A | |
Recruiting |
NCT05830734 -
Injection of Freshly Collected Autologous Adipose Tissue Additional to Bascom's Cleft Lift Surgery
|
N/A | |
Terminated |
NCT03458663 -
Randomized Trial Comparing Prevena and ActiV.A.C. System to Convetional Care After Bascom's Cleft Lift Surgery
|
N/A | |
Completed |
NCT05404243 -
Clinical Trial to Test the Phenolization in Sacrococcygeal Pilonidal Disease
|
Phase 4 | |
Active, not recruiting |
NCT03772873 -
MIPE for Pilonidal Disease
|
||
Recruiting |
NCT02330159 -
Feasibility of a Novel Technique for Pilonidal Wound Healing
|
N/A | |
Completed |
NCT02186964 -
Comparison of Tension Free Primary Closure, Karydaks and Limberg Flap Methods
|
N/A | |
Completed |
NCT01268969 -
Comparison Between Two Different Technique in Treatment of Chronic Pilonidal Disease
|
N/A |